Rodin Therapeutics
Rodin Therapeutics was a biotechnology company that developed treatments for Alzheimer's disease. Founded in 2013, it was acquired in 2019 by Alkermes.
All edits by Lena Kourkouta
Edits on 11 Jan, 2019
Lena Kourkouta
Edits made to:
Article (+13/-13 characters)
Article
On June 27, 2013 Rodin Therapeutics closed their seed funding round with an undisclosed amount of funding from Johnson & Johnson Development Corporation and Atlas VentureAtlas Venture.
Find more companies like Rodin Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.